Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neonatal screening by DNA microarray: spots and chips.

Nancy S Green1, Kenneth A Pass

  • 1March of Dimes Birth Defect Foundation, 1275 Mamaroneck Avenue, White Plains, New York, 10605, USA. ngreen@modimes.org

Nature Reviews. Genetics
|February 18, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Return of results is important to heterogeneous research participants: A single-site survey.

Journal of clinical and translational science·2026
Same author

Newborn screening results for sickle cell disease from the ASH Consortium on Newborn Screening in Africa (CONSA).

Blood advances·2026
Same author

Growth measurements in Ugandan children with sickle cell anaemia from a hydroxyurea (hydroxycarbamide) treatment trial relative to unaffected sibling controls.

British journal of haematology·2025
Same author

HABIT Efficacy Trial Intervention Improves Elements of General and Disease-Specific Quality of Life in Youth With Sickle Cell Disease.

Pediatric blood & cancer·2025
Same author

Incident Stroke in Pediatric Sickle Cell Anemia Despite Overall Improved Transcranial Doppler Velocity in a Ugandan Hydroxyurea Trial: Antecedent and Ongoing Risks.

Pediatric blood & cancer·2025
Same author

Academic Proficiency in Ugandan Children With Sickle Cell Anemia: A Cross-Sectional Study.

Pediatric blood & cancer·2025
Same journal

Genetic origins and constraints of evolutionary innovation.

Nature reviews. Genetics·2026
Same journal

Single-cell four-omics with CHARM.

Nature reviews. Genetics·2026
Same journal

Molecular integration of seasonal temperature signals in flowering time control.

Nature reviews. Genetics·2026
Same journal

RBPscan measures protein-RNA interactions in living cells.

Nature reviews. Genetics·2026
Same journal

Revisiting retinal and macular degeneration in the genomics era.

Nature reviews. Genetics·2026
Same journal

How evolution builds three morphs from one genome.

Nature reviews. Genetics·2026
See all related articles

Newborn screening (NBS) can be improved using DNA microarray technology for early detection of genetic disorders. This method offers multiplex analysis but requires careful consideration of data management and ethical implications.

Area of Science:

  • Genetics
  • Public Health
  • Bioinformatics

Background:

  • Newborn screening (NBS) is crucial for early detection and treatment of pre-symptomatic genetic disorders in infants.
  • Current NBS protocols utilize protein-based assays and PCR, which may have limitations in scope and efficiency.
  • Advancements in genetic technologies prompt a re-evaluation of existing screening methodologies.

Purpose of the Study:

  • To evaluate the potential of DNA microarray technology as an improved first-stage screening tool in newborn screening programs.
  • To compare the advantages and disadvantages of DNA microarrays against current protein-based assays for NBS.
  • To highlight the necessary considerations for implementing advanced genomic technologies in NBS.

Main Methods:

  • The study proposes a conceptual framework for integrating DNA microarray technology into the initial phase of newborn screening.

Related Experiment Videos

  • It involves a comparative analysis of DNA microarrays versus traditional protein assays, considering factors like multiplexing capabilities.
  • Discussion includes the technical challenges and requirements for handling large genomic datasets generated by microarrays.

    • Main Results:

    • DNA microarray technology offers multiplex analysis, enabling simultaneous screening for multiple genetic disorders.
    • Potential advantages include increased sensitivity and broader coverage compared to current protein assays.
    • Disadvantages identified include high initial costs and the complexity of analyzing and storing large-scale genomic data.

    Conclusions:

    • DNA microarrays represent a promising technological advancement for enhancing the first stage of newborn screening.
    • Successful implementation necessitates addressing technical challenges, including data management and bioinformatics infrastructure.
    • Crucial ethical considerations, such as paediatric genomic data privacy and parental consent, must be carefully navigated for optimal NBS program design.